These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8301318)

  • 1. Neurochemical and histopathologic alterations characteristic of Pick's disease in a non-demented individual.
    Sparks DL; Danner FW; Davis DG; Hackney C; Landers T; Coyne CM
    J Neuropathol Exp Neurol; 1994 Jan; 53(1):37-42. PubMed ID: 8301318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered serotonergic and cholinergic synaptic markers in Pick's disease.
    Sparks DL; Markesbery WR
    Arch Neurol; 1991 Aug; 48(8):796-9. PubMed ID: 1898253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve growth factor receptor immunoreactivity within the nucleus basalis (Ch4) in Parkinson's disease: reduced cell numbers and co-localization with cholinergic neurons.
    Mufson EJ; Presley LN; Kordower JH
    Brain Res; 1991 Jan; 539(1):19-30. PubMed ID: 1849779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease, and Pick's disease.
    Sparks DL; Woeltz VM; Markesbery WR
    Arch Neurol; 1991 Jul; 48(7):718-21. PubMed ID: 1859299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
    Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
    Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathological study on the nucleus basalis of Meynert in Pick's disease.
    Mizukami K; Kosaka K
    Acta Neuropathol; 1989; 78(1):52-6. PubMed ID: 2735190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical observations in a case of Pick's disease.
    Yates CM; Simpson J; Maloney AF; Gordon A
    J Neurol Sci; 1980 Nov; 48(2):257-63. PubMed ID: 7431041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lobar atrophy without Pick bodies.
    Hulette CM; Crain BJ
    Clin Neuropathol; 1992; 11(3):151-6. PubMed ID: 1611728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions.
    Yokota O; Tsuchiya K; Arai T; Yagishita S; Matsubara O; Mochizuki A; Tamaoka A; Kawamura M; Yoshida H; Terada S; Ishizu H; Kuroda S; Akiyama H
    Acta Neuropathol; 2009 Apr; 117(4):429-44. PubMed ID: 19194716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of precerebellar nuclei in Pick's disease.
    Braak H; Braak E
    Exp Neurol; 1998 Oct; 153(2):351-65. PubMed ID: 9784294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pick and focal brain atrophy].
    Förstl H; Baldwin B
    Fortschr Neurol Psychiatr; 1994 Sep; 62(9):345-55. PubMed ID: 7959518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography and histopathology in Pick's disease.
    Kamo H; McGeer PL; Harrop R; McGeer EG; Calne DB; Martin WR; Pate BD
    Neurology; 1987 Mar; 37(3):439-45. PubMed ID: 3493451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pick's disease: a modern approach.
    Dickson DW
    Brain Pathol; 1998 Apr; 8(2):339-54. PubMed ID: 9546291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical and ultrastructural studies of Pick's disease.
    Murayama S; Mori H; Ihara Y; Tomonaga M
    Ann Neurol; 1990 Apr; 27(4):394-405. PubMed ID: 2162145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Where fronto-temporal dementia should be placed in the history of Pick's disease and related disorders].
    Ikeda K
    Seishin Shinkeigaku Zasshi; 2000; 102(6):529-42. PubMed ID: 10979314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of muscarinic acetylcholine receptors in atypical Pick's disease without Pick bodies.
    Odawara T; Shiozaki K; Iseki E; Hino H; Kosaka K
    J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):965-7. PubMed ID: 12810794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of advanced glycation end products of the Maillard reaction in Pick's disease.
    Kimura T; Ikeda K; Takamatsu J; Miyata T; Sobue G; Miyakawa T; Horiuchi S
    Neurosci Lett; 1996 Nov; 219(2):95-8. PubMed ID: 8971788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KP1 expression of ghost Pick bodies, amyloid P-positive astrocytes and selective nigral degeneration in early onset Picks disease.
    Kobayashi K; Hayashi M; Fukutani Y; Miyazu K; Shiozawa M; Muramori F; Aoki T; Koshino Y
    Clin Neuropathol; 1999; 18(5):240-9. PubMed ID: 10505433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neocortical morphometry and cholinergic neurochemistry in Pick's disease.
    Hansen LA; Deteresa R; Tobias H; Alford M; Terry RD
    Am J Pathol; 1988 Jun; 131(3):507-18. PubMed ID: 3381880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pick's disease. A special type of pathological aging of the brain].
    Seitelberger F
    Aktuelle Gerontol; 1982 Nov; 12(6):200-5. PubMed ID: 6130712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.